FHL 2 |
Familial hemophagocytic lymphohistiocytosis type 2 |
BBB |
Blood–brain barrier |
SNV |
Single nucleotide variant |
NK |
Natural Killer |
CTL |
CD8+ cytotoxic T lymphocytes |
MHC I |
Major histocompatibility complex class I |
KIR |
Killer cell immunoglobulin receptor |
KLR |
Killer cell lectin like receptor |
CNS |
Central nervous system |
VEGF |
Vascular endothelial growth factor |
MPEG1 |
Macrophage expressed gene/protein 1 |
MACPF/CDC |
Membrane attach complex perforin like/cholesteral dependent cytosylin |
MAC |
Membrane attack complex |
EGF |
Epidermal growth factor |
MS |
Multiple sclerosis |
ALPS |
Autoimmune lymphoproliferative syndrome |
HLH |
Hemophagocytic Lymphohistiocytosis |
EBV |
Epstein Barr Virus |
CMV |
Cytomegalovirus |
Stx11 |
Syntaxin 11 |
StxBP2 |
Syntaxin binding protein 2 |
NVU |
Neurovascular unit |
CSF |
Cerebral spinal fluid |
CEC |
Cerebral endothelial cell |
TMEV |
Theiler’s Murine encephalomyelitis virus |
PIFS |
Peptide induced fatal syndrome |
ECM |
Experimental cerebral malaria |
CM |
Cerebral malaria |
VHF |
Viral hemorrhagic fever |
LCMV |
Lymphocytic choriomeningitis virus |